Hainan Huayan Secures Multiple Strategic Investments to Jointly Expand the Global Bioactive Peptide Market
On March 9, the strategic investment cooperation signing ceremony of Hainan Huayan Collagen Technology Co., Ltd. (hereinafter referred to as “Hainan Huayan”), an enterprise located in Haikou National High-Tech Industrial Development Zone, was held in Haikou. At the ceremony, Hainan Huayan officially reached strategic investment cooperation with Bloomage Yuanyou Fund, Langhan Nonghui Emerging Industry Fund (hereinafter referred to as “Langhan Nonghui Fund”) and Wenrun Investment.
The substantial participation of multiple capitals not only represents the high recognition of the capital market for Hainan Huayan’s technological strength, industrial value and growth potential after two decades of deep cultivation in the field of marine biological peptides, but also injects multiple core impetuses into the enterprise, including capital, industrial resources and channel layout. This will help Hainan Huayan accelerate its pace towards the capital market and enter a new stage of high-quality global development.
It is reported that in this cooperation, Bloomage Yuanyou Fund will rely on Bloomage Biotechnology’s industrial chain accumulation in the medical and health consumption sector to carry out all-round collaboration with Hainan Huayan in fields such as medical aesthetic raw materials and functional skin care products, realizing two-way empowerment of technology and market. Langhan Nonghui Fund will open channels for the enterprise to connect with the East Asian medical aesthetic industrial chain and support its global layout. Backed by Wen’s Co., Ltd., a leading agricultural and animal husbandry enterprise, Wenrun Investment will bring multiple values to Hainan Huayan, including diversified expansion of raw material supply chain, industrial chain integration and standardized corporate governance, helping the enterprise break through the boundaries of raw material application and improve its full-link industrial layout. Meanwhile, the participation of Hainan Free Trade Port Fund and Haikou National High-Tech Zone Fund further reflects the local government’s high expectations for Hainan Huayan in promoting the construction of a full ecological chain of high-end medical and health consumer goods in the Free Trade Port.
“Hainan Huayan is a leader in fish collagen peptides in China. Based on its profound accumulation in this field, it can carry out extensive horizontal expansion and develop more peptide categories with its advanced enzyme cleavage technology. Therefore, I believe Hainan Huayan will become a platform-based enterprise in the collagen industry in the future,” said Lin Ge, partner of Bloomage Yuanyou Fund, who highly recognized the commercial value of Hainan Huayan. It is reported that Bloomage Yuanyou Fund was jointly established by Bloomage Biotechnology, Langzi Hanya Asset Management Co., Ltd., together with Hainan Free Trade Port Fund and Haikou National High-Tech Zone Fund.
Founded in 2005, Hainan Huayan is a national high-tech enterprise, a benchmark enterprise in Hainan’s marine economy sector, and one of the earliest enterprises in China engaged in the R&D and production of hydrolyzed collagen peptides. Over the past two decades, rooted in the Hainan Free Trade Port, the enterprise has relied on the unique marine biological resources and taken advanced biological enzymatic hydrolysis technology as the core to convert marine biological by-products into high-value-added small molecule peptides, building a solid technical barrier in the field of bioactive peptides. Its products are widely used in core fields such as medical aesthetic raw materials, functional foods and general health.
Guo Hongxing, Chairman of Hainan Huayan, stated that the enterprise will take this strategic cooperation as a new starting point and focus on five core directions: scientific research and innovation, integration of production capacity and supply chain, domestic and international market layout, standardized corporate governance, and industrial ecosystem building. It will integrate resources from all parties to carry out joint R&D, expand large-scale, standardized and intelligent production capacity, and build a dual-circulation market pattern at home and abroad. With standardized operation, it will sprint for the capital market and strive to build a leader in the bioactive peptide market. In the future, Hainan Huayan will join hands with strategic partners, taking technological innovation as the sail, industrial collaboration as the oar and capital strength as the wind, to deeply cultivate the blue-ocean market of bioactive peptides, promote “Chinese peptides” to define global standards, and at the same time support the development of industrial clusters such as biological products and marine economy in the Hainan Free Trade Port, contributing to the rise of China’s bio-manufacturing industry and the development of the general health industry.
”The strategic investment secured by Hainan Huayan from multiple capitals is not only a high recognition of the enterprise’s value by the capital market, but also a favorable and encouraging event for the park’s industries to pursue high-end development, innovation and growth,” said a relevant person in charge of Haikou National High-Tech Zone. Next, the park will integrate resources of various industrial funds, fully rely on the “investment first then equity” policy, guide more “patient capital” to invest in early-stage, small-sized and hard-tech enterprises, facilitate efficient connection between enterprises and capital, and achieve high-quality development of technological innovation enterprises and the park’s economy and society.
Post time: Mar-16-2026
